Biblio Discovery — Demo Discovery Service

28 results for "Annette M. Molinaro"

Showing 1–20 · 0.66 seconds · RSS

  1. Journal Article

    Functional network alterations in young brain tumor patients with radiotherapy-induced memory impairments and vascular injury

    Melanie A. Morrison; Sadie Walter; Sabine Mueller et al.

    Frontiers in Neurology, Vol. 13 · 2022 · English · DOAJ Scopus

    BackgroundCognitive impairment and cerebral microbleeds (CMBs) are long-term side-effects of cranial radiation therapy (RT). Previously we showed that memory function is disrupted in young patients and that the rate of cognitive decline correlates with CMB development. However, vascular injury…

  2. Journal Article

    Construction and performance of a clinical prediction rule for ureteral stone without the use of race or ethnicity: A new STONE score

    Christopher L. Moore; Cary P. Gross; Louis Hart et al.

    Journal of the American College of Emergency Physicians Open, Vol. 5 No. 6 · 2024 · English · DOAJ Scopus

    Abstract Objectives The original STONE score was designed to predict the presence of uncomplicated renal colic and the corresponding absence of alternate serious etiologies. It was retrospectively derived and prospectively validated and resulted in five variables: Sex (male gender), Timing (acute…

  3. Journal Article Full text

    Enhanced cell deconvolution of peripheral blood using DNA methylation for high-resolution immune profiling

    Lucas A. Salas; Ze Zhang; Devin C. Koestler et al.

    Nature Communications · 2022 · English · OpenAlex Scopus

    DNA methylation microarrays can be employed to interrogate cell-type composition in complex tissues. Here, we expand reference-based deconvolution of blood DNA methylation to include 12 leukocyte subtypes (neutrophils, eosinophils, basophils, monocytes, naïve and memory B cells, naïve and memory…

    Also available at: DOAJ

  4. Journal Article

    Identification of a foetal epigenetic compartment in adult human kidney

    John K. Wiencke; Ze Zhang; Devin C. Koestler et al.

    Epigenetics, Vol. 17 No. 3 · 2022 · English · DOAJ Scopus

    The mammalian kidney has extensive repair capacity; however, identifying adult renal stem cells has proven elusive. We applied an epigenetic marker of foetal cell origin (FCO) in diverse human tissues as a probe for developmental cell persistence, finding a 5.4-fold greater FCO proportion in…

  5. Journal Article

    Comparative Sensitivity of Intraoperative Motor Evoked Potential Monitoring in Predicting Postoperative Neurologic Deficits: Nondegenerative versus Degenerative Myelopathy

    Aaron J. Clark; Michael Safaee; Dean Chou et al.

    Global Spine Journal, Vol. 6 · 2016 · English · DOAJ Scopus

    Study Design Retrospective review. Objective Intraoperative motor evoked potential (MEP) monitoring in spine surgery may assist surgeons in taking corrective measures to prevent neurologic deficits. The efficacy of monitoring MEPs intraoperatively in patients with myelopathy from nondegenerative…

  6. Journal Article

    Characterization of Metabolic, Diffusion, and Perfusion Properties in GBM: Contrast-Enhancing versus Non-Enhancing Tumor

    Adam Autry; Joanna J. Phillips; Stojan Maleschlijski et al.

    Translational Oncology, Vol. 10 No. 6 · 2017 · English · DOAJ Scopus

    BACKGROUND: Although the contrast-enhancing (CE) lesion on T1-weighted MR images is widely used as a surrogate for glioblastoma (GBM), there are also non-enhancing regions of infiltrative tumor within the T2-weighted lesion, which elude radiologic detection. Because non-enhancing GBM (Enh−)…

  7. Journal Article

    Association of Diffusion and Anatomic Imaging Parameters with Survival for Patients with Newly Diagnosed Glioblastoma Participating in Two Different Clinical Trials

    Qiuting Wen; Laleh Jalilian; Janine M. Lupo et al.

    Translational Oncology, Vol. 8 No. 6 · 2015 · English · DOAJ Scopus

    PURPOSE: To evaluate the time course and association with survival of anatomic lesion volumes and diffusion imaging parameters for patients with newly diagnosed glioblastoma who were treated with radiation and concurrently with either temozolomide and enzastaurin (TMZ+enza cohort) or temozolomide…

  8. Journal Article

    Glioma immune microenvironment composition calculator (GIMiCC): a method of estimating the proportions of eighteen cell types from DNA methylation microarray data

    Steven C. Pike; John K. Wiencke; Ze Zhang et al.

    Acta Neuropathologica Communications, Vol. 12 No. 1 · 2024 · English · DOAJ Scopus

    Abstract A scalable platform for cell typing in the glioma microenvironment can improve tumor subtyping and immune landscape detection as successful immunotherapy strategies continue to be sought and evaluated. DNA methylation (DNAm) biomarkers for molecular classification of tumor subtypes have…

  9. Journal Article

    Assessment of immune cell profiles among post-menopausal women in the Women’s Health Initiative using DNA methylation-based methods

    Emily Nissen; Alexander Reiner; Simin Liu et al.

    Clinical Epigenetics, Vol. 15 No. 1 · 2023 · English · DOAJ Scopus

    Abstract Background Over the past decade, DNA methylation (DNAm)-based deconvolution methods that leverage cell-specific DNAm markers of immune cell types have been developed to provide accurate estimates of the proportions of leukocytes in peripheral blood. Immune cell phenotyping using DNAm…

  10. Journal Article Full text

    Improving the Generalizability of Deep Learning for T2-Lesion Segmentation of Gliomas in the Post-Treatment Setting

    Jacob Ellison; Francesco Caliva; Pablo Damasceno et al.

    Bioengineering, Vol. 11 No. 5 · 2024 · English · DOAJ Scopus

    Although fully automated volumetric approaches for monitoring brain tumor response have many advantages, most available deep learning models are optimized for highly curated, multi-contrast MRI from newly diagnosed gliomas, which are not representative of post-treatment cases in the clinic…

  11. Journal Article

    Improving glioma drug delivery: A multifaceted approach for glioma drug development

    Marybeth G. Yonk; Megan A. Lim; Charee M. Thompson et al.

    Pharmacological Research, Vol. 208 · 2024 · English · DOAJ Scopus

    Glioma is one of the most common central nervous system (CNS) cancers that can be found within the brain and the spinal cord. One of the pressing issues plaguing the development of therapeutics for glioma originates from the selective and semipermeable CNS membranes: the blood-brain barrier (BBB)…

  12. Journal Article

    Hierarchical deconvolution for extensive cell type resolution in the human brain using DNA methylation

    Ze Zhang; John K. Wiencke; Karl T. Kelsey et al.

    Frontiers in Neuroscience, Vol. 17 · 2023 · English · DOAJ Scopus

    IntroductionThe human brain comprises heterogeneous cell types whose composition can be altered with physiological and pathological conditions. New approaches to discern the diversity and distribution of brain cells associated with neurological conditions would significantly advance the study of…

  13. Journal Article

    Detection of glioma infiltration at the tumor margin using quantitative stimulated Raman scattering histology

    Melike Pekmezci; Ramin A. Morshed; Pranathi Chunduru et al.

    Scientific Reports, Vol. 11 No. 1 · 2021 · English · DOAJ Scopus

    Abstract In the management of diffuse gliomas, the identification and removal of tumor at the infiltrative margin remains a central challenge. Prior work has demonstrated that fluorescence labeling tools and radiographic imaging are useful surgical adjuvants with macroscopic resolution. However…

  14. Journal Article

    Relationship of In Vivo MR Parameters to Histopathological and Molecular Characteristics of Newly Diagnosed, Nonenhancing Lower-Grade Gliomas

    Tracy L. Luks; Tracy Richmond McKnight; Llewellyn E. Jalbert et al.

    Translational Oncology, Vol. 11 No. 4 · 2018 · English · DOAJ Scopus

    The goal of this research was to elucidate the relationship between WHO 2016 molecular classifications of newly diagnosed, nonenhancing lower grade gliomas (LrGG), tissue sample histopathology, and magnetic resonance (MR) parameters derived from diffusion, perfusion, and 1H spectroscopic imaging…

  15. Journal Article

    Genetic predisposition to altered blood cell homeostasis is associated with glioma risk and survival

    Linda Kachuri; Geno A. Guerra; Taishi Nakase et al.

    Nature Communications, Vol. 16 No. 1 · 2025 · English · DOAJ Scopus

    Abstract Glioma is a highly fatal and heterogeneous brain tumor with few known risk factors. Our study examines genetically predicted variability in blood cell indices in relation to glioma risk and survival in 3418 cases and 8156 controls. We find that increased platelet to lymphocyte ratio (PLR)…

  16. Journal Article

    A cytokine-based serum proteomic score is a prognostic biomarker for immunotherapy in head and neck cancer

    Md Saiful Islam Saif; Kartik Sehgal; Ze Zhang et al.

    Cancer Immunology, Immunotherapy, Vol. 75 No. 1 · 2025 · English · DOAJ Scopus

    Abstract Despite advances with anti-programmed death (PD)-1-based immunotherapy for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC), identifying who will benefit from these therapies remains challenging. In a prospective, multicenter study, serum levels of 92 cytokines were…

  17. Journal Article

    Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma

    Lakshmi Nayak; Annette M. Molinaro; Katherine B. Peters et al.

    Clinical Cancer Research · 2020 · English · OpenAlex Scopus

    Abstract Purpose: VEGF is upregulated in glioblastoma and may contribute to immunosuppression. We performed a phase II study of pembrolizumab alone or with bevacizumab in recurrent glioblastoma. Patients and Methods: Eighty bevacizumab-naïve patients with recurrent glioblastoma were randomized to…

  18. Journal Article

    Methylation cytometric pretreatment blood immune profiles with tumor mutation burden as prognostic indicators for survival outcomes in head and neck cancer patients on anti-PD-1 therapy

    Ze Zhang; Kartik Sehgal; Keisuke Shirai et al.

    npj Precision Oncology, Vol. 8 No. 1 · 2024 · English · DOAJ Scopus

    Abstract Tissue biomarkers for immune checkpoint inhibitor (ICI) response are limited by tumor sample heterogeneity and availability. This study identifies clinically actionable pretreatment blood biomarkers that are associated with ICI treatment response and survival in recurrent/metastatic head…

  19. Journal Article

    Novel radiotherapy target definition using AI-driven predictions of glioblastoma recurrence from metabolic and diffusion MRI

    Nate Tran; Tracy L. Luks; Yan Li et al.

    npj Digital Medicine, Vol. 8 No. 1 · 2025 · English · DOAJ Scopus

    Abstract The current standard-of-care (SOC) practice for defining the clinical target volume (CTV) for radiation therapy (RT) in patients with glioblastoma still employs an isotropic 1–2 cm expansion of the T2-hyperintensity lesion, without considering the heterogeneous infiltrative nature of these…